#Breaking #News #USA
FDA's Approval Of A Cheaper Drug For Hepatitis C Will Likely Expand Treatment
Mavyret, recently approved by the Food And Drug Administration, can cure hepatitis C in eight weeks, at a cost of $26,400. Though still expensive, that's well below the price of other options.
Read more on NPR
FDA's Approval Of A Cheaper Drug For Hepatitis C Will Likely Expand Treatment
Mavyret, recently approved by the Food And Drug Administration, can cure hepatitis C in eight weeks, at a cost of $26,400. Though still expensive, that's well below the price of other options.
Read more on NPR
Comments
Post a Comment